Assessment of effect of educational intervention on awareness, attitude, and practice regarding pharmacovigilance practices among patients admitted in a tertiary healthcare center in South India

Ananya Vishvas; Pratheeksha Harindran; Shiva Murthy Nanjundappa

doi:10.18203/2319-2003.ijbcp20251837

Authors

Ananya Vishvas Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Dayananda Sagar University, Harohalli, Kanakapura Taluk, Ramanagara District, Karnataka, India
Pratheeksha Harindran Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Dayananda Sagar University, Harohalli, Kanakapura Taluk, Ramanagara District, Karnataka, India
Shiva Murthy Nanjundappa Department of Pharmacology, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Dayananda Sagar University, Harohalli, Kanakapura Taluk, Ramanagara District, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20251837

Keywords:

Pharmacovigilance, Adverse drug reactions, Patient education, Knowledge, attitude, and practice

Abstract

Background: Adverse drug reactions (ADRs) remain a significant contributor to global morbidity and mortality. Despite the launch of the Pharmacovigilance Programme of India (PvPI) to improve ADR reporting, under-reporting persists largely due to limited public awareness. Active consumer participation is essential for the success of pharmacovigilance systems. Objective of the study was to assess the impact of an educational intervention on the knowledge, attitude, and practice (KAP) regarding pharmacovigilance among inpatients at a rural tertiary healthcare center in South India.

Methods: A prospective crossover study was conducted using a pre-validated KAP questionnaire. Adult inpatients aged 18–75 years, excluding healthcare workers, were enrolled via convenient sampling. An educational session tailored for non-medical individuals was delivered, followed by re-administration of the same KAP tool to assess changes. The target sample size was 175, with an additional 5 participants enrolled within the study period. Ethical approval and informed consent were obtained.

Results: The study included 180 participants (96 males, 84 females) with a mean age of 40.15±15.30 years. Post-intervention, awareness of what constitutes an ADR rose markedly from 27.8% to 97.8%, and belief in the universal possibility of side effects increased from 20% to 98.9%. Willingness to report ADRs in the future improved slightly from 95% to 96.1%, although actual reporting practice remained limited. Overall, the educational session significantly enhanced participant awareness, attitudes, and understanding related to pharmacovigilance.

Conclusions: Structured educational interventions can substantially improve public engagement in pharmacovigilance. Strengthening patient awareness and involvement, particularly in rural settings, is vital to advancing drug safety monitoring in India.

Metrics

Metrics Loading ...

References

Kommu S, Carter C, Whitfield P. Adverse Drug Reactions. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.

Doshi N, Prajapati B, Selvaraj L. A Pharmacovigilance Study on Adverse Drug Reaction Profile at a Tertiary Care Teaching Hospital from Western Part of India. Int J Pharm Investig. 2025;15(2):562-72. DOI: https://doi.org/10.5530/ijpi.20250144

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65-71. DOI: https://doi.org/10.4103/0253-7613.150344

Suke SG, Kosta P, Negi H. Role of Pharmacovigilance in India: An overview. Online J Public Health Inform. 2015;7(2):e223. DOI: https://doi.org/10.5210/ojphi.v7i2.5595

Singh J, Singh H, Rohilla R, Kumar R, Gautam CS. Lack of Awareness of Pharmacovigilance among Young Health-care Professionals in India: An Issue Requiring Urgent Intervention. Int J Appl Basic Med Res. 2018;8(3):158-63. DOI: https://doi.org/10.4103/ijabmr.IJABMR_423_17

Kumar R Sr, Jindal A Sr, Garg P, Kaur A, Kumar S, Tilak Raj R, et al. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study. Cureus. 2023;15(9):e44984. DOI: https://doi.org/10.7759/cureus.44984

Valinciute A, Gerbutaviciene RJ, Paukstaitiene R, Kubiliene L. Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study. Healthcare. 2023;11(8):1133. DOI: https://doi.org/10.3390/healthcare11081133

Jha N, Rathore DS, Shankar PR, Bhandary S, Pandit RB, Gyawali S, et al. Effect of an educational intervention on knowledge and attitude regarding pharmacovigilance and consumer pharmacovigilance among community pharmacists in Lalitpur district, Nepal. BMC Res Notes. 2017;10(1):4. DOI: https://doi.org/10.1186/s13104-016-2343-5

Staniszewska A, Dąbrowska-Bender M, Olejniczak D, Duda-Zalewska A, Bujalska-Zadrożny M. Patient knowledge on reporting adverse drug reactions in Poland. Patient Prefer Adherence. 2016;11:47-53. DOI: https://doi.org/10.2147/PPA.S117572

Matos C, van Hunsel F, Joaquim J. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol. 2015;71(7):883-90. DOI: https://doi.org/10.1007/s00228-015-1867-2

Mohammad A, Bheemavarapu H, Khan MU, Khan A, Ahmad A, Hassali MAA, et al. A cross-sectional survey to assess the knowledge, attitudes and common barriers to the reporting of adverse drug reactions by the general public in Malaysia. J Pharm Pract Res. 2018;48:348-55. DOI: https://doi.org/10.1002/jppr.1412

Hingorani SK, Shah AY, Mehta CD. Educational intervention to improve knowledge, attitude, and practice of pharmacovigilance among resident doctors at a tertiary care hospital. Perspect Clin Res. 2023;14:75-80. DOI: https://doi.org/10.4103/picr.picr_37_22

Ian Osoro N, Suhaib KP, Jamuna Rani R, Rajanandh MG. Barriers to and facilitators of healthcare professionals in ADR reporting in a tertiary care hospital in India. BMC Health Serv Res. 2025;25(1):166. DOI: https://doi.org/10.1186/s12913-024-12139-w

Shabaraya AR, Gautham JB, Tantry SK. A Study On Barriers Towards Reporting of Adverse Drug Reactions Among Healthcare Professionals, Clinical Management, and Drug Development. Int J Pharm Sci. 2024;2(8):3861-7.

Smith MY, Benattia I. The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. Drug Saf. 2016;39(9):779-85. DOI: https://doi.org/10.1007/s40264-016-0426-9

Shukla S, Sharma P, Gupta P, Pandey S, Agrawal R, Rathour D, et al. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India. Curr Drug Saf. 2024;19(2):172-90. DOI: https://doi.org/10.2174/1574886318666230428144120